Burkina Faso vs Niger: Number of people requiring preventive treatment for schistosomiasis
Burkina Faso
4.46 million people
in 2024
Niger
5.10 million people
in 2024
Burkina Faso rank
19th
Niger rank
16th
Number of people requiring preventive treatment for schistosomiasis over time
- Burkina Faso
- Niger
How they compare
Niger currently reports 5.10 million people against 4.46 million people in Burkina Faso, a difference of 635,800 people.
That makes Niger's figure about 1.1 times Burkina Faso's.
The two have swapped places 2 times across 15 shared years of data; in 2010 it was Niger ahead.
Burkina Faso ranks 19th and Niger ranks 16th of 52 countries.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.88 million people | 5.02 million people | 1.14 million people | Niger |
| 2020s | 3.48 million people | 8.69 million people | 5.21 million people | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of people requiring preventive treatment for schistosomiasis, Burkina Faso or Niger?
- Niger, at 5.10 million people against 4.46 million people in Burkina Faso as of 2024.
- What is the difference in number of people requiring preventive treatment for schistosomiasis between Burkina Faso and Niger?
- 635,800 people, with Niger ahead.
- How many years of comparable data are there for Burkina Faso and Niger?
- 15 years are reported by both, from 2010 to 2024.
- How do Burkina Faso and Niger rank globally for number of people requiring preventive treatment for schistosomiasis?
- Burkina Faso ranks 19th and Niger ranks 16th of 52 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Number of people requiring preventive treatment for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Population requiring preventive chemotherapy for schistosomiasis.